Redx Pharma (REDX.L) Financials

£30.3 M

Mkt cap, 24-May-2017

£30.5 M

Revenue FY, 2017
Net income (FY, 2017)1.5 M
EBITDA (FY, 2017)2.3 M
EBIT (FY, 2017)2 M
Cash, 30-Sep-201723.8 M


Income Statement


GBPFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017


1.3 m30.5 m

Operating expense total

4.9 m28.5 m


(3.5 m)(9.2 m)(14.7 m)2.3 m

EBITDA margin, %



(3.6 m)(4 m)(9.4 m)(14.9 m)2 m

EBIT margin, %


Pre tax profit

(3.8 m)(4.3 m)(8.8 m)(15.4 m)1.6 m

Income tax expense

389.2 k910 k650 k(114 k)(118 k)

Net Income

(3.4 m)(3.4 m)(8.2 m)(15.5 m)1.5 m

Balance Sheet


GBPFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017


515.8 k45.8 k1 m2.9 m9.4 m5.8 m23.8 m

Accounts Receivable

112.9 k331.9 k2.7 m114 k452 k469 k

Current Assets

628.7 k377.7 k4.4 m6.6 m12.3 m7.9 m27 m


44.9 k32 k327.2 k130 k353 k533 k222 k


309 k309 k309 k

Total Assets

967.6 k688.1 k5 m7.1 m13.8 m9.4 m27.7 m

Accounts Payable

1 m483.2 k1.4 m1.2 m1.6 m1.6 m4 m

Current Liabilities

1 m483.2 k4.5 m5.2 m4.1 m7.7 m13.4 m

Non-Current Liabilities

865.3 k2 m

Total Debt

2 m

Total Liabilities

1 m1.3 m4.5 m5.2 m6.1 m7.7 m13.4 m

Additional Paid-in Capital

3.5 k4.1 k5.6 k7 k650 k936 k1.3 m

Retained Earnings

(3.4 m)(3.4 m)(8.2 m)(15.5 m)1.5 m

Total Equity

(34.9 k)(660.4 k)415.1 k1.8 m7.7 m1.7 m14.3 m

Debt to Equity Ratio

1.2 x

Debt to Assets Ratio

0.2 x

Financial Leverage

-27.7 x-1 x11.9 x3.9 x1.8 x5.5 x1.9 x

Cash Flow


GBPFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(3.4 m)(3.4 m)(8.2 m)(15.5 m)1.5 m

Cash From Operating Activities

(3.9 m)(2.2 m)(6.5 m)(12.5 m)14.1 m

Cash From Financing Activities

5.2 m4.1 m13.4 m9.3 m4 m

Net Change in Cash

968.1 k1.9 m6.5 m(3.7 m)18 m

Income Taxes Paid

910 k650 k(114 k)


GBPY, 2017


210.2 k

Financial Leverage

1.9 x
Report incorrect company information